Symbol: |
NFE2L2
|
Description: |
nuclear factor (erythroid-derived 2)-like 2 [Source:HGNC Symbol;Acc:7782]
|
Location: |
Chr2:178092323-178257425[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:77
Gene |
Compound |
Gen_sig |
Exp_pattern |
NFE2L2 |
Crotonosid |
0.032 |
Up |
NFE2L2 |
NSC 156274 |
0.003 |
Down |
NFE2L2 |
NSC 295642 |
0.039 |
Up |
NFE2L2 |
CHALCONE ANALOG |
0.014 |
Up |
NFE2L2 |
VOBTUSINE, (3E)-HYDROXY- |
0.041 |
Up |
NFE2L2 |
Maxima isoflavone D |
0.021 |
Down |
NFE2L2 |
NSC 405361 |
0.007 |
Up |
NFE2L2 |
NSC 405789 |
0.013 |
Up |
NFE2L2 |
NSC 49692 |
0.036 |
Up |
NFE2L2 |
RAPAMYCIN PRODRUG |
0.025 |
Up |
NFE2L2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.025 |
Up |
NFE2L2 |
NSC 62349 |
0.034 |
Up |
NFE2L2 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.016 |
Down |
NFE2L2 |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.013 |
Down |
NFE2L2 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.002 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:17
SNP |
Gene |
SNP_location |
SNP_allele |
rs201824058 |
NFE2L2 |
Chr2:178095478 |
A/C |
rs77547666 |
NFE2L2 |
Chr2:178095495 |
G/C |
|
miRNA:
~ Export ~
|
Records:52
Total:4 Current:1
[First] [Prev]  Next Last 
|